Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gyöngyi, Kirschner"'
Autor:
Bence Bakos, Balázs Szili, Boglárka Szabó, Péter Horváth, Gyöngyi Kirschner, János P. Kósa, Erzsébet Toldy, Péter Lakatos, Ádám G. Tabák, István Takács
Publikováno v:
BMC Medical Genetics, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract Background Vitamin D metabolism and obesity have been linked by several studies, however the reason for this association is unclear. Our objective was to investigate potential correlations between genetic variants in key enzymes of vitamin D
Externí odkaz:
https://doaj.org/article/d538abbb320d4f3d995725b320088a2c
Autor:
Balázs Szili, Peter L. Lakatos, Peter Horvath, Bence Bakos, Erzsébet Toldy, Boglárka Szabó, Gyöngyi Kirschner, Adam G. Tabak, János P. Kósa, István Takács
Publikováno v:
BMC Medical Genetics, Vol 21, Iss 1, Pp 1-8 (2020)
BMC Medical Genetics
BMC Medical Genetics
Background Vitamin D metabolism and obesity have been linked by several studies, however the reason for this association is unclear. Our objective was to investigate potential correlations between genetic variants in key enzymes of vitamin D metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c140fedeabb1ce6e48357623fd3db01
http://link.springer.com/article/10.1186/s12881-020-01065-3
http://link.springer.com/article/10.1186/s12881-020-01065-3
Autor:
Bálint Tobiás, Peter Horvath, Andrea Kövesdi, Zsolt Nagy, Peter L. Lakatos, Gyöngyi Kirschner, Gergely Lakatos, István Takács, Kristóf Árvai, Bernadett Balla, János P. Kósa
Publikováno v:
Orvosi Hetilap. 157:1429-1437
Tyrosine kinase inhibitors are widely used for treatment of certain oncohematological diseases. Several clinical studies have confirmed that specific BCR-ABL tyrosine kinase inhibitors alter the physiological process of bone tissue in a complex and u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcc338d7736e6e089088005debfcb914
https://doi.org/10.1556/650.2016.30525
https://doi.org/10.1556/650.2016.30525
Autor:
Bernadett Balla, Gergely Lakatos, Péter Lakatos, Gyöngyi Kirschner, János P. Kósa, Peter Horvath
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::782c7bb2d866118ba7f61a066760f749
https://doi.org/10.1530/endoabs.49.gp37
https://doi.org/10.1530/endoabs.49.gp37
Autor:
Laszlo Kornyei, György Fekete, Bernadett Balla, János P. Kósa, Zsuzsanna Putz, Gyöngyi Kirschner, Kristóf Árvai, Attila Tóth, Béla Merkely, Hajnalka Vágó, Péter Lakatos, István Likó, Bálint Tobiás, István Takács, V Horvath, Zsolt B. Nagy
Publikováno v:
Journal of Next Generation Sequencing & Applications.
Next generation sequencing (NGS) is becoming a valuable tool in clinical decisions. Here, we discuss the case of a family (2 parents with 3 children) with hypertrophic cardiomyopathy where we applied a NGS method developed by us to determine the gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5065f84c50d01a841117b1f0f0b248d
https://doi.org/10.4172/2469-9853.1000145
https://doi.org/10.4172/2469-9853.1000145
Autor:
Gyöngyi, Kirschner, Bernadett, Balla, János, Kósa, Péter, Horváth, Andrea, Kövesdi, Gergely, Lakatos, István, Takács, Zsolt, Nagy, Bálint, Tóbiás, Kristóf, Árvai, Péter, Lakatos
Publikováno v:
Orvosi hetilap. 157(36)
Tyrosine kinase inhibitors are widely used for treatment of certain oncohematological diseases. Several clinical studies have confirmed that specific BCR-ABL tyrosine kinase inhibitors alter the physiological process of bone tissue in a complex and u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::beb35bc4927a355f9d5bab4b8f58cb97
https://pubmed.ncbi.nlm.nih.gov/27596510
https://pubmed.ncbi.nlm.nih.gov/27596510
Autor:
Gyöngyi Kirschner, Peter Horvath, Karina Kató, Bálint Tobiás, János P. Kósa, Valéria Klujber, Kristóf Árvai, Peter L. Lakatos, Bernadett Balla
Publikováno v:
Scientific Reports
Next generation sequencing (NGS) is a rapidly developing area in genetics. Utilizing this technology in the management of disorders with complex genetic background and not recurrent mutation hot spots can be extremely useful. In this study, we applie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3ba3a1e7bb768d8fa3f263c174afff5
Autor:
Bernadett Balla, Andrea Kövesdi, János P. Kósa, Zsolt Nagy, Peter L. Lakatos, Bálint Tobiás, Gyöngyi Kirschner, István Takács, Peter Horvath, Gergely Lakatos, Kristóf Árvai
Publikováno v:
Molecular Medicine Reports
Numerous clinical observations have confirmed that breakpoint cluster region-abelson fusion oncoprotein tyrosine kinase inhibitors used in leukemia treatment alter bone physiology in a complex manner. The aim of the present study was to analyze the w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa0090d8dfcbb6167e036901ef6b062
https://pubmed.ncbi.nlm.nih.gov/27430367
https://pubmed.ncbi.nlm.nih.gov/27430367